Hong Kong Chronic Disease Scheme: HK$2.7 Billion Savings
Hong Kong’s Chronic Disease Co-Care Pilot Scheme could save the city a staggering HK$2.7 billion, according to the latest reports. The Health Bureau’s initiative, launched in November 2023, is already making waves by screening residents aged 45 and above for diabetes, high blood pressure, and high blood lipids.With nearly 60% of participants completing the initial screenings, the programme has identified and referred thousands for medical follow-up. The scheme is set to evolve into a broader platform, integrating hepatitis B screening to further refine early detection strategies. This proactive approach, supported by subsidized treatments and lab tests, is poised to reshape Hong Kong’s healthcare landscape. News Directory 3 keeps you informed on these crucial healthcare developments. Discover what’s next for Hong kong’s pioneering health program.
Hong Kong Chronic Disease Screening Pilot Could Save Millions
Updated June 11, 2025
Hong Kong’s ongoing pilot scheme for chronic disease screening has the potential to save HK$2.7 billion (US$344 million) in medical expenses if 200,000 people participate, according to health authorities. The Health Bureau announced Tuesday that the Chronic Disease Co-Care Pilot Scheme, launched in November 2023, will evolve into a broader co-care “platform” covering more diseases, including hepatitis B.
Nearly 60% of the 131,200 participants in the chronic disease screening program have undergone screening for diabetes, high blood pressure, or high blood lipids, according to a bureau paper submitted to the Legislative Council. Of those screened, about 31,100 (40%) were diagnosed with one of these conditions and referred for medical follow-up.
The scheme subsidizes screening for these three diseases for individuals aged 45 and above through participating family doctors. Participants diagnosed with any of the conditions receive subsidized treatment and necessary lab tests.
“preliminary analysis shows that the scheme has an important value in improving resource allocation and reducing the burden of the healthcare system,” the bureau said, citing a government-commissioned university study.
What’s next
The Health Bureau plans to expand the chronic disease screening program into a co-care platform, incorporating additional diseases like hepatitis B to further enhance early detection and management of chronic conditions in Hong Kong.